Response by Good et al to Letter Regarding Article, "pannexin-1 Channels as an Unexpected New Target of the Antihypertensive Drug Spironolactone"

Miranda E. Good; Yu Hsin Chiu; Ivan K.H. Poon; Iris Z. Jaffe; Douglas A. Bayliss; Brant E. Isakson; Kodi S. Ravichandran

doi:10.1161/CIRCRESAHA.118.313080

Response by Good et al to Letter Regarding Article, "pannexin-1 Channels as an Unexpected New Target of the Antihypertensive Drug Spironolactone"

Miranda E. Good, Yu Hsin Chiu, Ivan K.H. Poon, Iris Z. Jaffe, Douglas A. Bayliss, Brant E. Isakson, Kodi S. Ravichandran

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e88-e89
Journal	Circulation research
Volume	122
Issue number	11
DOIs	https://doi.org/10.1161/CIRCRESAHA.118.313080
State	Published - May 25 2018

Access to Document

10.1161/CIRCRESAHA.118.313080

Cite this

@article{08faefa165ae4530bc307de2405aa4e9,

title = "Response by Good et al to Letter Regarding Article, {"}pannexin-1 Channels as an Unexpected New Target of the Antihypertensive Drug Spironolactone{"}",

author = "Good, {Miranda E.} and Chiu, {Yu Hsin} and Poon, {Ivan K.H.} and Jaffe, {Iris Z.} and Bayliss, {Douglas A.} and Isakson, {Brant E.} and Ravichandran, {Kodi S.}",

note = "Funding Information: This work was supported by National Institutes of Health (NIH) P01 HL120840 (to K.S. Ravichandran, B.E. Isakson, D.A. Bayliss), NIH HL119290 to I.Z. Jaffe, NHMRC GNT1013584 and GNT1125033 to I.K.H. Poon, and NIH Training Grant HL007284 and NIH HL131399 to M.E. Good.",

year = "2018",

month = may,

day = "25",

doi = "10.1161/CIRCRESAHA.118.313080",

language = "English",

volume = "122",

pages = "e88--e89",

journal = "Circulation research",

issn = "0009-7330",

number = "11",

}

TY - JOUR

T1 - Response by Good et al to Letter Regarding Article, "pannexin-1 Channels as an Unexpected New Target of the Antihypertensive Drug Spironolactone"

AU - Good, Miranda E.

AU - Chiu, Yu Hsin

AU - Poon, Ivan K.H.

AU - Jaffe, Iris Z.

AU - Bayliss, Douglas A.

AU - Isakson, Brant E.

AU - Ravichandran, Kodi S.

N1 - Funding Information: This work was supported by National Institutes of Health (NIH) P01 HL120840 (to K.S. Ravichandran, B.E. Isakson, D.A. Bayliss), NIH HL119290 to I.Z. Jaffe, NHMRC GNT1013584 and GNT1125033 to I.K.H. Poon, and NIH Training Grant HL007284 and NIH HL131399 to M.E. Good.

PY - 2018/5/25

Y1 - 2018/5/25

UR - http://www.scopus.com/inward/record.url?scp=85053894029&partnerID=8YFLogxK

U2 - 10.1161/CIRCRESAHA.118.313080

DO - 10.1161/CIRCRESAHA.118.313080

M3 - Letter

C2 - 29798905

AN - SCOPUS:85053894029

SN - 0009-7330

VL - 122

SP - e88-e89

JO - Circulation research

JF - Circulation research

IS - 11

ER -

Response by Good et al to Letter Regarding Article, "pannexin-1 Channels as an Unexpected New Target of the Antihypertensive Drug Spironolactone"

Access to Document

Other files and links

Cite this